With the Workday Segment of the business growing to over £60m ARR and Cash topping +16% to £126m with NO Debt this is a business that has great long term growth as leading consultants in Workday Products and in the Generative AI space having invested more than £10m into training their 3,000 staff in this area. The COVID contracts have ended in their healthcare segment thus returning to more organic growth figures and the share price since 2021 reflected this.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.